MyHashtagDiscovery Network
Current space

Members

Filtered creator directory for "pharmaceutical".

Add Pin Explore Posts
Directory 201.5K Indexed posts 43M Verified 0
Active AuthorsRecent indexed creators Registered MembersAccount directory Completed ProfilesProfiles with public details VerifiedTrusted member signals
201.5KActive members
43MIndexed posts
286KDetailed profiles
16Sources in this view

Active authors

Showing directory results matching your search with real activity counts for visible profiles.

Page 1 | 15 shown
A
Amneal to Report Fourth Quarter and Full Year 2025 Results
Amneal Announces FDA Approval of Denosumab Biosimilars
Amneal Pharmaceuticals Added to S&P SmallCap 600® Index
Amneal to Report Fourth Quarter and Full Year 2025 Results
Amneal Pharmaceuticals LLC avatar
@Amneal Pharmaceuticals LLC
Amneal Pharmaceuticals
Feb 2, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 4Posts 1Sources 0Reputation
Latest signal 0 reactions
Amneal to Report Fourth Quarter and Full Year 2025 Results
globenewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
A
ARS Pharmaceuticals Receives FDA Approval to Remove Age
FDA Issues Complete Response Letter for neffy® (epinephrine
ARS Pharmaceuticals Receives FDA Approval to Remove Age
ARS Pharmaceuticals, Inc. avatar
@ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals,
Apr 8, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 2Posts 1Sources 0Reputation
Latest signal 0 reactions
ARS Pharmaceuticals Receives FDA Approval to Remove Age
globenewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
B
BioMarin Receives Complete Response Letter (CRL) from FDA for Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A
BioMarin Receives Complete Response Letter (CRL) from FDA for Valoctocogene Roxaparvovec Ge...
BioMarin Pharmaceutical Inc. avatar
@BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical
Jan 28, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
BioMarin Receives Complete Response Letter (CRL) from FDA for Valoctocogene Roxaparvovec Gene Therapy for Severe Hemo...
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
F
Chrissy Teigen Launches Fertility Out Loud Campaign to Empower Those with Fertility Challenges to Get the Help they Need
Chrissy Teigen Launches Fertility Out Loud Campaign to Empower Those with Fertility Challen...
Ferring Pharmaceuticals avatar
@Ferring Pharmaceuticals
Ferring Pharmaceuticals
Apr 6, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Chrissy Teigen Launches Fertility Out Loud Campaign to Empower Those with Fertility Challenges to Get the Help they N...
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
G
Generic Drugs Continue to Deliver Billions in Savings to the U.S. Healthcare System, New Re...
Generic Pharmaceutical Association avatar
@Generic Pharmaceutical Association
Generic Pharmaceutical
Feb 12, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Generic Drugs Continue to Deliver Billions in Savings to the U.S. Healthcare System, New Report Finds
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
I
INOVIO Initiates Phase 1 Clinical Trial Of Its COVID-19 Vaccine and Plans First Dose Today
INOVIO Pharmaceuticals, Inc. avatar
@INOVIO Pharmaceuticals, Inc.
INOVIO Pharmaceuticals,
Apr 2, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
INOVIO Initiates Phase 1 Clinical Trial Of Its COVID-19 Vaccine and Plans First Dose Today
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
I
Ionis Pharmaceuticals Licenses IONIS-HTT Rx to Partner Following Successful Phase 1/2a Study in Patients with Huntington's Disease
Pfizer and Ionis announce discontinuation of vupanorsen clinical development program
Ionis Pharmaceuticals Licenses IONIS-HTT Rx to Partner Following Successful Phase 1/2a Stud...
Ionis Pharmaceuticals, Inc. avatar
@Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals,
Mar 1, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 2Posts 1Sources 0Reputation
Latest signal 0 reactions
Ionis Pharmaceuticals Licenses IONIS-HTT Rx to Partner Following Successful Phase 1/2a Study in Patients with Hunting...
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
J
Janssen Provides Portfolio Update
Janssen Provides Portfolio Update
Janssen Pharmaceutical Companies of Johnson & Johnson avatar
@Janssen Pharmaceutical Companies of Johnson & Johnson
Janssen Pharmaceutical
Jan 29, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Janssen Provides Portfolio Update
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
J
Jazz Pharmaceuticals Enters Exclusive Licensing Agreement with Saniona to Develop and Commercialize SAN2355
Jazz Pharmaceuticals Enters Exclusive Licensing Agreement with Saniona to Develop and Comme...
Jazz Pharmaceuticals plc avatar
@Jazz Pharmaceuticals plc
Jazz Pharmaceuticals
Feb 6, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Jazz Pharmaceuticals Enters Exclusive Licensing Agreement with Saniona to Develop and Commercialize SAN2355
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
O
Ohr Pharmaceutical Announces Efficacy Results from the MAKO
Ohr Pharmaceutical Announces Efficacy Results from the MAKO
Ohr Pharmaceutical, Inc. avatar
@Ohr Pharmaceutical, Inc.
Ohr Pharmaceutical,
Apr 6, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Ohr Pharmaceutical Announces Efficacy Results from the MAKO
globenewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
O
Oramed Subsidiary Oravax Reports Positive Preliminary Phase 1 Data for its Oral Covid-19 Vaccine
Oramed Subsidiary Oravax Reports Positive Preliminary Phase 1 Data for its Oral Covid-19 Va...
Oramed Pharmaceuticals Inc. avatar
@Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals
Jan 29, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Oramed Subsidiary Oravax Reports Positive Preliminary Phase 1 Data for its Oral Covid-19 Vaccine
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
P
Pelage Pharmaceuticals Advances Clinical Program with First Patients Dosed in Phase 2 Study for Hair Loss and GV-Led $14M Series A-1
Pelage Pharmaceuticals Advances Clinical Program with First Patients Dosed in Phase 2 Study...
Pelage Pharmaceuticals avatar
@Pelage Pharmaceuticals
Pelage Pharmaceuticals
Jan 27, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Pelage Pharmaceuticals Advances Clinical Program with First Patients Dosed in Phase 2 Study for Hair Loss and GV-Led...
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
P
PBMs Affirm Readiness to Assist Patients with COVID-19
PBMs Affirm Readiness to Assist Patients with COVID-19
Pharmaceutical Care Management Association avatar
@Pharmaceutical Care Management Association
Pharmaceutical Care
Jan 28, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
PBMs Affirm Readiness to Assist Patients with COVID-19
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
R
EYLEA® (aflibercept) Injection Improves Diabetic Retinopathy and Reduces Vision-Threatenin...
Regeneron Pharmaceuticals, Inc. avatar
@Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals,
Apr 6, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 6Posts 2Sources 0Reputation
Latest signal 0 reactions
EYLEA® (aflibercept) Injection Improves Diabetic Retinopathy and Reduces Vision-Threatening Complications in Phase 3...
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
R
Rivus Pharmaceuticals Launches with $35 Million Series A Financing to Develop Novel Treatments for Cardio-Metabolic Diseases
Rivus Pharmaceuticals Launches with $35 Million Series A Financing to Develop Novel Treatme...
Rivus Pharmaceuticals, Inc. avatar
@Rivus Pharmaceuticals, Inc.
Rivus Pharmaceuticals,
Jan 29, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Rivus Pharmaceuticals Launches with $35 Million Series A Financing to Develop Novel Treatments for Cardio-Metabolic D...
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts